SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-064358
Filing Date
2022-03-03
Accepted
2022-03-03 16:16:07
Documents
14
Period of Report
2022-03-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d265803d8k.htm   iXBRL 8-K 25371
2 EX-99.1 d265803dex991.htm EX-99.1 62212
6 GRAPHIC g265803g0222012814019.jpg GRAPHIC 2083
  Complete submission text file 0001193125-22-064358.txt   219964

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tyra-20220303.xsd EX-101.SCH 2836
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tyra-20220303_lab.xml EX-101.LAB 17979
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tyra-20220303_pre.xml EX-101.PRE 11245
8 EXTRACTED XBRL INSTANCE DOCUMENT d265803d8k_htm.xml XML 3343
Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Filer) CIK: 0001863127 (see all company filings)

IRS No.: 831476348 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40800 | Film No.: 22708941
SIC: 2834 Pharmaceutical Preparations